Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
Danielle Sambo, Min Lin, Anthony Owens, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 102

Showing 26-50 of 102 citing articles:

Functional characterization of the biogenic amine transporters on human macrophages
Phillip Mackie, Adithya Gopinath, Dominic Montas, et al.
JCI Insight (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 24
Molecular Imaging of Alzheimer’s Disease-Related Sigma-1 Receptor in the Brain via a Novel Ru-Mediated Aromatic 18F-deoxyfluorination Probe
Ping Bai, Frederick A. Bagdasarian, Yulong Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6207-6217
Closed Access | Times Cited: 5
Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes
Jordan T. Yorgason, David M. Hedges, J. Daniel Obray, et al.
Psychopharmacology (2020) Vol. 237, Iss. 5, pp. 1317-1330
Open Access | Times Cited: 35
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson’s disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin
Chenhong Guo, Ting Cao, Long Tai Zheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 4, pp. 499-507
Open Access | Times Cited: 33
Stimulation of Sigma-1 Receptor Protects against Cardiac Fibrosis by Alleviating IRE1 Pathway and Autophagy Impairment
Jing Qu, Miaoling Li, Dongxu Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 31
The complex role of inflammation and gliotransmitters in Parkinson's disease
Adithya Gopinath, Phillip Mackie, Leah Phan, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105940-105940
Open Access | Times Cited: 22
Molecular Mechanisms of Amphetamines
Maarten E. A. Reith, Margaret E. Gnegy
Handbook of experimental pharmacology (2019), pp. 265-297
Closed Access | Times Cited: 35
Rewarding Effects of Nicotine in Adolescent and Adult Male and Female Rats as Measured Using Intracranial Self-stimulation
Song Xue, Azin Behnood‐Rod, Ryann Wilson, et al.
Nicotine & Tobacco Research (2018) Vol. 22, Iss. 2, pp. 172-179
Open Access | Times Cited: 33
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats
Genmeng Yang, Liu Liu, Ruilin Zhang, et al.
Toxicology Research (2020) Vol. 9, Iss. 3, pp. 202-211
Open Access | Times Cited: 32
Sigma-1 receptor chaperones rescue nucleocytoplasmic transport deficit seen in cellular and Drosophila ALS/FTD models
Pin-Tse Lee, Jean-Charles Liévens, Shao-Ming Wang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 30
α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability
Abeer Dagra, Douglas R. Miller, Min Lin, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors
Ritu Prajapati, Su Hui Seong, Se Eun Park, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 26
The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics
Jared VanderZwaag, Torin Halvorson, Kira Dolhan, et al.
Neurochemical Research (2022) Vol. 48, Iss. 4, pp. 1129-1166
Closed Access | Times Cited: 17
Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development
Wanyu Tang, Zhiyuan Ma, Bang Li, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Imaging sigma receptors in the brain: New opportunities for diagnosis of Alzheimer’s disease and therapeutic development
Hongmei Jia, Ying Zhang, Yiyun Huang
Neuroscience Letters (2018) Vol. 691, pp. 3-10
Closed Access | Times Cited: 30
In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Min Lin, Phillip Mackie, Fatima Shaerzadeh, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 22
MicroRNAs in drug addiction: Current status and future perspectives
Yue Zhao, Feng Qin, Shuang Han, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108215-108215
Closed Access | Times Cited: 16
Sex‐specific susceptibility to psychotic‐like states provoked by prenatal THC exposure: Reversal by pregnenolone
Roberto Frau, Miriam Melis
Journal of Neuroendocrinology (2023) Vol. 35, Iss. 2
Open Access | Times Cited: 9
Amphetamine-induced reverse transport of dopamine does not require cytosolic Ca2+
Jonatan Fullerton Støier, Ainoa Konomi-Pilkati, Mia Apuschkin, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 105063-105063
Open Access | Times Cited: 9
Novel therapeutics in development for the treatment of stimulant-use disorder
Erica J. Young, László Radnai, В. А. Приходько, et al.
Current Opinion in Neurobiology (2024) Vol. 87, pp. 102898-102898
Open Access | Times Cited: 3
The Sigma-1 Receptor: When Adaptive Regulation of Cell Electrical Activity Contributes to Stimulant Addiction and Cancer
Olivier Soriani, Saı̈d Kourrich
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 24
Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives
Francesca Serena Abatematteo, Mauro Niso, Marialessandra Contino, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6359-6359
Open Access | Times Cited: 18
Cardiovascular disease associated with methamphetamine use: a review
Jared Tobolski, Douglas B. Sawyer, Sharon J. Song, et al.
Heart Failure Reviews (2022) Vol. 27, Iss. 6, pp. 2059-2065
Closed Access | Times Cited: 14
Neural circuit dynamics of drug-context associative learning in the mouse hippocampus
Yanjun Sun, Lisa M. Giocomo
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Heterogeneity of dopamine release sites in health and degeneration
Joseph J. Lebowitz, Habibeh Khoshbouei
Neurobiology of Disease (2019) Vol. 134, pp. 104633-104633
Open Access | Times Cited: 21

Scroll to top